Barry Zee, PhD, is a Principal Scientist in the Proteomics Group at Cell Signaling Technology. He earned his PhD in Molecular Biology from Princeton University and completed postdoctoral research at Brigham and Women's Hospital and Boston Children’s Hospital. Barry has authored multiple publications on proteomics and protein modification analysis.
